Roquefort Therapeutics plc (LON:ROQ)

Roquefort Therapeutics Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.18	0.34	0.54	2.32	0.9
Cash & Short-Term Investments	0.18	0.34	0.54	2.32	0.9
Cash Growth	-69.29%	-37.26%	-76.87%	158.19%	-
Accounts Receivable	0.03	-	-	-	0.02
Other Receivables	-	0.01	0.11	0.05	2.14
Receivables	0.03	0.01	0.11	0.05	2.15
Prepaid Expenses	-	0.01	0.05	0.06	0.03
Total Current Assets	1.76	0.36	0.69	2.42	3.08
Property, Plant & Equipment	0.04	0.04	0.05	-	-
Goodwill	-	0.28	0.28	0.28	0.28
Other Intangible Assets	3.86	5.06	5.06	5.06	1.2
Total Assets	5.66	5.75	6.09	7.77	4.56
Accounts Payable	0.13	0.02	0.14	0.07	0.04
Accrued Expenses	-	0.16	0.16	0.21	0.15
Short-Term Debt	0.38	0.4	-	-	-
Total Current Liabilities	0.63	0.58	0.31	0.28	0.2
Long-Term Deferred Tax Liabilities	0.28	0.28	0.28	0.28	0.28
Total Liabilities	0.91	0.86	0.59	0.56	0.48
Common Stock	1.57	1.36	1.29	1.29	0.72
Additional Paid-In Capital	4.73	4.62	4.4	4.4	3.46
Retained Earnings	-5.76	-5.27	-4.29	-2.55	-0.91
Comprehensive Income & Other	4.2	4.18	4.1	4.06	0.82
Shareholders' Equity	4.75	4.89	5.5	7.21	4.08
Total Liabilities & Equity	5.66	5.75	6.09	7.77	4.56
Total Debt	0.38	0.4	-	-	-
Net Cash (Debt)	-0.2	-0.06	0.54	2.32	0.9
Net Cash Growth	-	-	-76.87%	158.19%	-
Net Cash Per Share	-0.00	-0.00	0.00	0.02	0.04
Filing Date Shares Outstanding	157.44	135.74	129.15	129.15	71.9
Total Common Shares Outstanding	157.44	135.74	129.15	129.15	71.9
Working Capital	1.13	-0.22	0.39	2.15	2.88
Book Value Per Share	0.03	0.04	0.04	0.06	0.06
Tangible Book Value	0.89	-0.45	0.16	1.86	2.6
Tangible Book Value Per Share	0.01	-0.00	0.00	0.01	0.04

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.